Ironic technology: Old age and the implantable cardioverter defibrillator in US health care

被引:37
作者
Kaufman, Sharon R. [1 ]
Mueller, Paul S. [2 ]
Ottenberg, Abigale L. [2 ]
Koenig, Barbara A. [2 ]
机构
[1] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA 94118 USA
[2] Mayo Clin, Rochester, MN USA
关键词
USA; Aging society; US health care; risk prevention; ethics and policy; medical technology; heart failure; HEART-FAILURE; MEDICARE COVERAGE; LIFE EXTENSION; DEATH; PREVENTION; THERAPY; RISK; END; ICD;
D O I
10.1016/j.socscimed.2010.09.052
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We take the example of cardiac devices, specifically the implantable cardioverter defibrillator, or ICD, to explore the complex cultural role of technology in medicine today. We focus on persons age 80 and above, for whom ICD use is growing in the U.S. We highlight an ironic feature of this device. While it postpones death and 'saves' life by thwarting a lethal heart rhythm, it also prolongs living in a state of dying from heart failure. In that regard the ICD is simultaneously a technology of life extension and dying. We explore that irony among the oldest age group those whose considerations of medical interventions are framed by changing societal assumptions of what constitutes premature death, the appropriate time for death and medicine's goals in an aging society. Background to the rapidly growing use of this device among the elderly is the 'technological imperative' in medicine, bolstered today by the value given to evidence-based studies. We show how evidence contributes to standards of care and to the expansion of Medicare reimbursement criteria. Together, those factors shape the ethical necessity of physicians offering and patients accepting the ICD in late life. Two ethnographic examples document the ways in which those factors are lived in treatment discussions and in expectations about death and longevity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6 / 14
页数:9
相关论文
共 64 条
[1]  
[Anonymous], 2006, Heart Advis, V9, P6
[2]  
ARMSTRONG D., 2007, BIOSOCIETIES, V2, P73, DOI DOI 10.1017/S1745855207005066
[3]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[4]  
Buxton AE, 2006, AM J GERIATR CARDIOL, V15, P361
[5]  
Callahan D, 2009, TAMING THE BELOVED BEAST: HOW MEDICAL TECHNOLOGY COSTS ARE DESTROYING OUR HEALTH CARE SYSTEM, P1
[6]  
Cassell EricJ., 1991, NATURE SUFFERING GOA
[7]   Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention [J].
Chan, Paul S. ;
Nallamothu, Brahmajee K. ;
Spertus, John A. ;
Masoudi, Frederick A. ;
Bartone, Cheryl ;
Kereiakes, Dean J. ;
Chow, Theodore .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01) :16-U38
[8]  
Cleveland Clinic, 2010, BIV PAC
[9]   The implantable cardiac defibrillator - Is the glass half empty or half full? [J].
de Lissovoy, Gregory .
MEDICAL CARE, 2007, 45 (05) :371-373
[10]   Redefining life while forestalling death: Living with an implantable cardioverter defibrillator after a sudden cardiac death experience [J].
Dickerson, SS .
QUALITATIVE HEALTH RESEARCH, 2002, 12 (03) :360-372